Skip to main content
. 2014 Jan 3;472(5):1552–1557. doi: 10.1007/s11999-013-3446-0

Table 1.

Baseline demographic and clinical data

Demographic and clinical data Control group Tranexamic acid group Significance*
Number 234 154
Age (years) 56.7 ± 14.6 57.2 ± 14.3 0.747
Sex (female/male) 111/123 79/75
Weight (kg) 64.1 ± 10.6 64.7 ± 12.6 0.573
Body mass index (kg/m2) 25.3 ± 4.6 25.2 ± 4.3 0.742
ASA status (I/II/III) 35/153/46 12/111/31
Diagnosis
 Osteoarthritis and dysplasia 105 81
 Osteonecrosis 114 65
 Miscellaneous 15 8

* Student’s t-test; mean ± SD; ASA = American Society of Anesthesiologists.